Inovio Pharmaceuticals Inc. Q4 Loss decreases, but misses estimates

Inovio Pharmaceuticals Inc. (INO) revealed Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.

The company's earnings came in at -$54.5 million, or -$0.22 per share. This compares with -$106.9 million, or -$0.50 per share, in last year's fourth quarter.

Analysts on average had expected the company to earn -$0.17 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 84.5% to $0.13 million from $0.84 million last year.

Inovio Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q4): -$54.5 Mln. vs. -$106.9 Mln. last year.
-EPS (Q4): -$0.22 vs. -$0.50 last year.
-Analyst Estimates: -$0.17
-Revenue (Q4): $0.13 Mln vs. $0.84 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT